{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T09:31:43Z","timestamp":1768901503091,"version":"3.49.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1097\/hjh.0000000000001204","type":"journal-article","created":{"date-parts":[[2016,12,17]],"date-time":"2016-12-17T13:31:10Z","timestamp":1481981470000},"page":"493-500","source":"Crossref","is-referenced-by-count":63,"title":["Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies"],"prefix":"10.1097","volume":"35","author":[{"given":"Fabrice","family":"Bonnet","sequence":"first","affiliation":[]},{"given":"Amalia","family":"Gastaldelli","sequence":"additional","affiliation":[]},{"given":"Florence","family":"Pihan-Le bars","sequence":"additional","affiliation":[]},{"given":"Andrea","family":"Natali","sequence":"additional","affiliation":[]},{"given":"Ronan","family":"Roussel","sequence":"additional","affiliation":[]},{"given":"John","family":"Petrie","sequence":"additional","affiliation":[]},{"given":"Jean","family":"Tichet","sequence":"additional","affiliation":[]},{"given":"Michel","family":"Marre","sequence":"additional","affiliation":[]},{"given":"Bernard","family":"Fromenty","sequence":"additional","affiliation":[]},{"given":"Beverley","family":"Balkau","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-12-20210208","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s10654-007-9181-7","article-title":"Prevalence of nonalcoholic fatty liver and characteristics in overweight adolescents in the general population","volume":"22","author":"Imhof","year":"2007","journal-title":"Eur J Epidemiol"},{"key":"R2-12-20210208","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1210\/jc.2012-3093","article-title":"Clinical review: nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications","volume":"98","author":"Targher","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-12-20210208","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO clinical practice guidelines for the management of nonalcoholic fatty liver disease.","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"R4-12-20210208","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"R5-12-20210208","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-230X-10-56","article-title":"Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S. I. R. study","volume":"10","author":"Balkau","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"R6-12-20210208","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2337\/diacare.21.5.732","article-title":"Prospective study of serum gamma-glutamyltransferase and risk of NIDDM","volume":"21","author":"Perry","year":"1998","journal-title":"Diabetes Care"},{"key":"R7-12-20210208","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2337\/dc08-1870","article-title":"Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis","volume":"32","author":"Fraser","year":"2009","journal-title":"Diabetes Care"},{"key":"R8-12-20210208","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00125-009-1602-6","article-title":"Risk factors for incident type 2 diabetes in individuals with a BMI of <27\u200akg\/m2: the role of gamma-glutamyltransferase. Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR)","volume":"53","author":"Gautier","year":"2010","journal-title":"Diabetologia"},{"key":"R9-12-20210208","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1161\/ATVBAHA.107.152298","article-title":"Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis","volume":"27","author":"Fraser","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R10-12-20210208","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.atherosclerosis.2008.01.019","article-title":"The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes","volume":"201","author":"Wannamethee","year":"2008","journal-title":"Atherosclerosis"},{"key":"R11-12-20210208","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"N Engl J Med"},{"key":"R12-12-20210208","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.atherosclerosis.2014.06.006","article-title":"Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies","volume":"236","author":"Kunutsor","year":"2014","journal-title":"Atherosclerosis"},{"key":"R13-12-20210208","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/hep.26495","article-title":"Importance of cardiometabolic risk factors in the association between nonalcoholic fatty liver disease and arterial stiffness in adolescents","volume":"58","author":"Huang","year":"2013","journal-title":"Hepatology"},{"key":"R14-12-20210208","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jhep.2014.01.009","article-title":"Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension","volume":"60","author":"Sung","year":"2014","journal-title":"J Hepatol"},{"key":"R15-12-20210208","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0140-6736(12)60987-8","article-title":"Diabetes and hypertension: the bad companions","volume":"380","author":"Ferrannini","year":"2012","journal-title":"Lancet"},{"key":"R16-12-20210208","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/HYPERTENSIONAHA.111.00439","article-title":"Euglycemic clamp insulin sensitivity and longitudinal systolic blood pressure: role of sex","volume":"62","author":"Petrie","year":"2013","journal-title":"Hypertension"},{"key":"R17-12-20210208","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.2337\/db10-1806","article-title":"Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women","volume":"60","author":"Bonnet","year":"2011","journal-title":"Diabetes"},{"key":"R18-12-20210208","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1007\/s00125-013-3021-y","article-title":"Parental history of type 2 diabetes, TCF7L2 variant and lower insulin secretion are associated with incident hypertension. Data from the DESIR and RISC cohorts","volume":"56","author":"Bonnet","year":"2013","journal-title":"Diabetologia"},{"key":"R19-12-20210208","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"R20-12-20210208","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/hep.22845","article-title":"Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population","volume":"49","author":"Gastaldelli","year":"2009","journal-title":"Hepatology"},{"key":"R21-12-20210208","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00125-004-1335-5","article-title":"The EGIR-RISC Study (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives","volume":"47","author":"Hills","year":"2004","journal-title":"Diabetologia"},{"key":"R22-12-20210208","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2337\/dc07-1788","article-title":"Influence of the ACE gene insertion\/deletion polymorphism on insulin sensitivity and impaired glucose tolerance in healthy subjects","volume":"31","author":"Bonnet","year":"2008","journal-title":"Diabetes Care"},{"key":"R23-12-20210208","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2337\/dc06-1519","article-title":"Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test","volume":"30","author":"Abdul-Ghani","year":"2007","journal-title":"Diabetes Care"},{"key":"R24-12-20210208","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.atherosclerosis.2014.12.045","article-title":"Circulating gamma glutamyltransferase and prediction of cardiovascular disease","volume":"238","author":"Kunutsor","year":"2015","journal-title":"Atherosclerosis"},{"key":"R25-12-20210208","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/hep.25555","article-title":"Fatty liver index, gamma-glutamyltransferase, and early carotid plaques","volume":"55","author":"Kozakova","year":"2012","journal-title":"Hepatology"},{"key":"R26-12-20210208","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/10715760410001694026","article-title":"Is serum gamma glutamyltransferase a marker of oxidative stress?","volume":"38","author":"Lee","year":"2004","journal-title":"Free Radic Res"},{"key":"R27-12-20210208","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/01.HYP.0000138070.47616.9d","article-title":"Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?","volume":"44","author":"Touyz","year":"2004","journal-title":"Hypertension"},{"key":"R28-12-20210208","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s11906-014-0432-1","article-title":"Glutathione-S-transferase M1 and T1 null genotypes are associated with hypertension risk: a systematic review and meta-analysis of 12 studies","volume":"16","author":"Eslami","year":"2014","journal-title":"Curr Hypertens Rep"},{"key":"R29-12-20210208","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/HJH.0b013e328341f1b2","article-title":"Polymorphisms of antioxidant enzymes, blood pressure and risk of hypertension","volume":"29","author":"Mansego","year":"2011","journal-title":"J Hypertens"},{"key":"R30-12-20210208","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/hep.23789","article-title":"Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data","volume":"52","author":"Ghouri","year":"2010","journal-title":"Hepatology"},{"key":"R31-12-20210208","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/MEG.0b013e32834b8d52","article-title":"Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase","volume":"23","author":"Lopez-Suarez","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R32-12-20210208","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/HJH.0000000000000532","article-title":"Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic risk","volume":"33","author":"Aneni","year":"2015","journal-title":"J Hypertens"},{"key":"R33-12-20210208","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/jgh.12643","article-title":"Clinical association between nonalcoholic fatty liver disease and the development of hypertension","volume":"29","author":"Ryoo","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"R34-12-20210208","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.2337\/diacare.28.12.2913","article-title":"Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men","volume":"28","author":"Wannamethee","year":"2005","journal-title":"Diabetes Care"},{"key":"R35-12-20210208","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1056\/NEJM198708063170605","article-title":"Insulin resistance in essential hypertension","volume":"317","author":"Ferrannini","year":"1987","journal-title":"N Engl J Med"},{"key":"R36-12-20210208","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cmet.2007.11.013","article-title":"Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis","volume":"7","author":"Biddinger","year":"2008","journal-title":"Cell Metab"},{"key":"R37-12-20210208","doi-asserted-by":"crossref","first-page":"G1068","DOI":"10.1152\/ajpgi.00249.2010","article-title":"Betaine improves nonalcoholic fatty liver and associated hepatic insulin resistance: a potential mechanism for hepatoprotection by betaine","volume":"299","author":"Kathirvel","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R38-12-20210208","doi-asserted-by":"crossref","first-page":"e0124778","DOI":"10.1371\/journal.pone.0124778","article-title":"Activation of the liver X receptor by agonist TO901317 improves hepatic insulin resistance via suppressing reactive oxygen species and JNK pathway","volume":"10","author":"Dong","year":"2015","journal-title":"PLoS One"},{"key":"R39-12-20210208","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1161\/01.RES.0000248212.86638.e9","article-title":"Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells","volume":"99","author":"Gutierrez","year":"2006","journal-title":"Circ Res"},{"key":"R40-12-20210208","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/00004872-200307000-00029","article-title":"Fasting blood glucose is independently associated with resting and exercise blood pressures and development of elevated blood pressure","volume":"21","author":"Bjornholt","year":"2003","journal-title":"J Hypertens"},{"key":"R41-12-20210208","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.2337\/dc11-2248","article-title":"Glycated hemoglobin and risk of hypertension in the atherosclerosis risk in communities study","volume":"35","author":"Bower","year":"2012","journal-title":"Diabetes Care"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HJH.0000000000001204","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:13:02Z","timestamp":1620954782000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004872-201703000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0000000000001204","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}